With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma||University of Michigan / Carl Koschmann, MD||Young Investigator Grants||2014||Michigan|
|Targeted Inhibition of Signaling Networks in Pediatric Glioblastoma Stem Cells||University of California Berkeley / Erin Simonds, PhD||Young Investigator Grants||2013||California|
|Targeting HMGA1 in Childhood ALL||The Johns Hopkins University School of Medicine / Amy M. Belton, PhD||Young Investigator Grants||2011||Maryland|
|A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor||Dana-Farber Cancer Institute / Shuning He, PhD||Young Investigator Grants||2015||Massachusetts|
|Investigation of Pediatric Rhabdomyosarcoma Recurrence through Single-Cell Sequencing||St. Jude Children's Research Hospital / Anand Patel, MD/PhD||Young Investigator Grants||2019||Tennessee|
|MYC-driven Core Regulatory Circuits in Neuroblastoma||Dana-Farber Cancer Institute / Mark Zimmerman, PhD||Young Investigator Grants||2018||Massachusetts|
|Virotherapy on Primary Neuroblastoma Cells||Cincinnati Children's Hospital Medical Center / Pin-Yi Wang||Young Investigator Grants||2010||Ohio|
|Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma||Dana-Farber Cancer Institute / David Debruyne, PhD||Young Investigator Grants||2016||Massachusetts|
|WIP1 Modulates Responsiveness of MB to Genotoxic Stress.||Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta / Robert Craig Castellino, MD||Young Investigator Grants||2006||Georgia|
|Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients||Vanderbilt University Medical Center / Rachael Schulte, MD||Young Investigator Grants||2018||Tennessee|